Indapamida Pharmakern

Indapamide, the active ingredient in Indapamida Pharmakern, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is indicated for the management of hypertension and for reducing edema associated with congestive heart failure in adult patients through effective diuresis, helping to lower blood pressure and improve fluid balance.

GNH USA supplies Indapamida Pharmakern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with consistent quality and regulatory adherence. The product complies with EU pharmacopeial standards and is available for bulk and individual packaging.

Indapamide is a thiazide‑like diuretic used in the management of cardiovascular conditions that involve fluid overload or elevated blood pressure.

Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. Edema associated with congestive heart failure: promotes diuresis to decrease peripheral fluid accumulation. Edema of renal or hepatic origin: assists in removal of excess fluid when clinically indicated.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased urination: frequent need to void. - Electrolyte disturbances: mild reductions in potassium or sodium. - Dizziness or light‑headedness: especially after standing. - Headache: transient cranial discomfort. - Nausea: mild gastrointestinal upset. - Fatigue: feeling of reduced energy.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Significant electrolyte imbalance: hypokalemia, hyponatremia, or hyperuricemia leading to gout attacks. - Allergic reactions: rash, itching, or angioedema. - Blood dyscrasias: agranulocytosis or thrombocytopenia. - Acute renal impairment: sudden decline in kidney function.

When prescribing Indapamide, clinicians should observe several precautionary measures to ensure safe use.

Electrolyte monitoring: regularly check serum potassium and sodium levels. Renal function assessment: evaluate creatinine clearance before initiation and during therapy. Gout risk: use cautiously in patients with a history of gout. Hepatic impairment: avoid or adjust dose in severe liver disease. Elderly patients: start at lower dose and monitor for orthostatic hypotension. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Lithium: concomitant use may increase lithium toxicity. - Cyclosporine: combined therapy can enhance nephrotoxic risk. - Antidiabetic agents: may potentiate hypoglycaemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may increase risk of hyperkalaemia and renal dysfunction. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce diuretic effect and impair renal function. - Beta‑blockers: additive blood pressure‑lowering effect may cause excessive hypotension.